{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T14:58:28Z","timestamp":1792249108778,"version":"4.4.0"},"reference-count":30,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n The 21st Century Cures Act expanded Medicare Advantage (MA) to include persons with kidney failure. Little is known about the impact of increased MA marketing for persons with end-stage kidney disease (ESKD).<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To examine varied perspectives on the expansion of MA to include persons with ESKD and associated marketing strategies.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This qualitative study of interviews conducted from January 21, 2022, to May 1, 2024, used a modified grounded theory and content analysis approach to analyze transcripts. Interviewees included executives from 8 MA plans, clinical leadership of 5 kidney care management companies, and leadership and staff of 6 dialysis organizations that varied in size (enrollment) from all US Census regions.<\/jats:p>\n <\/jats:sec>\n \n Exposure<\/jats:title>\n One-time, semistructured interviews. Interview questions focused on the perceived effects of the expansion of MA to include persons with kidney failure.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Thematic description of participant perspectives on the expansion of MA and associated marketing practices.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n A total of 48 interviews with 56 executives and staff from MA plans, kidney care management companies, and dialysis organizations were completed. Analysis found 3 major themes. First, organizations used various outreach approaches to inform persons with kidney failure of their expanded insurance options. Participants recognized that personal choice without undue influence is paramount when older or chronically ill adults are selecting their insurance coverage. Second, MA has potential benefits for persons with ESKD, and organizations expanded partnerships with brokers and\/or agencies to provide additional insurance-related resources. Third, the mass marketing approach used to advertise MA was ubiquitous and often reported as deceptive for older or chronically ill adults. Kidney health care professionals noted that constraints on eligibility, restricted health care networks, and limited benefits and services were frequently inadequate for the complex social and medical needs of their patient population.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this qualitative study, findings show that MA marketing to increase enrollment is pervasive and intensifies during open enrollment. Policymakers and industry experts should consider the complexity of insurance selection decisions and monitor accuracy of MA marketing of ESKD-specific benefits.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.16359","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T11:00:27Z","timestamp":1750158027000},"page":"e2516359","source":"Crossref","is-referenced-by-count":7,"title":["Expansion and Marketing of Medicare Advantage to Persons With End-Stage Kidney Disease"],"prefix":"10.1001","volume":"8","author":[{"given":"Joan F.","family":"Brazier","sequence":"first","affiliation":[{"name":"Department of Health Services, Policy & Practice, Brown University School of Public Health, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal N.","family":"Trivedi","sequence":"additional","affiliation":[{"name":"Department of Health Services, Policy & Practice, Brown University School of Public Health, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise A.","family":"Tyler","sequence":"additional","affiliation":[{"name":"Scripps Gerontology Center, Miami University, Oxford, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee R.","family":"Shield","sequence":"additional","affiliation":[{"name":"Department of Health Services, Policy & Practice, Brown University School of Public Health, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily A.","family":"Gadbois","sequence":"additional","affiliation":[{"name":"Department of Health Services, Policy & Practice, Brown University School of Public Health, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"issue":"14","key":"zoi250514r3","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1007\/s11606-024-08876-7","article-title":"Medicare Advantage under fire: public criticism and implications.","volume":"39","author":"Aaron","year":"2024","journal-title":"J Gen Intern Med"},{"issue":"4","key":"zoi250514r4","doi-asserted-by":"publisher","DOI":"10.1111\/1475-6773.14308","article-title":"Restrictiveness of Medicare Advantage provider networks across physician specialties.","volume":"59","author":"Feyman","year":"2024","journal-title":"Health Serv Res"},{"issue":"4","key":"zoi250514r5","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1001\/jamainternmed.2018.7639","article-title":"Analysis of drivers of disenrollment and plan switching among Medicare Advantage beneficiaries.","volume":"179","author":"Meyers","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"2","key":"zoi250514r6","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1007\/s11606-020-06534-2","article-title":"Narrow primary care networks in Medicare Advantage.","volume":"37","author":"Meyers","year":"2022","journal-title":"J Gen Intern Med"},{"issue":"5","key":"zoi250514r14","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1377\/hlthaff.2018.05428","article-title":"Limited Medigap consumer protections are associated with higher reenrollment in Medicare Advantage plans.","volume":"38","author":"Meyers","year":"2019","journal-title":"Health Aff (Millwood)"},{"issue":"10","key":"zoi250514r17","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1001\/jama.2023.1426","article-title":"Medicare Advantage enrollment among beneficiaries with end-stage renal disease in the first year of the 21st Century Cures Act.","volume":"329","author":"Nguyen","year":"2023","journal-title":"JAMA"},{"issue":"9","key":"zoi250514r18","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.32772","article-title":"Medicare Advantage enrollment following the 21st Century Cures Act in adults with end-stage renal disease.","volume":"7","author":"Nguyen","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"4","key":"zoi250514r22","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1468-0009.2005.00397.x","article-title":"Evaluating the quality of medical care. 1966.","volume":"83","author":"Donabedian","year":"2005","journal-title":"Milbank Q"},{"issue":"4","key":"zoi250514r25","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1007\/s11135-017-0574-8","article-title":"Saturation in qualitative research: exploring its conceptualization and operationalization.","volume":"52","author":"Saunders","year":"2018","journal-title":"Qual Quant"},{"issue":"2","key":"zoi250514r28","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1377\/hlthaff.2022.01044","article-title":"Narrow dialysis networks in Medicare Advantage: exposure by race, ethnicity, and dual eligibility.","volume":"42","author":"Oh","year":"2023","journal-title":"Health Aff (Millwood)"},{"issue":"7","key":"zoi250514r30","doi-asserted-by":"publisher","first-page":"882","DOI":"10.7326\/M23-2480","article-title":"Association of Medicare Advantage enrollment with financial burden of care: a retrospective cohort study.","volume":"177","author":"Park","year":"2024","journal-title":"Ann Intern Med"},{"key":"zoi250514r20","volume-title":"SAGE Research Methods Foundations","author":"Parker","year":"2019"},{"key":"zoi250514r21","first-page":"273","volume-title":"Handbook of Qualitative Research","author":"Strauss","year":"1994"},{"key":"zoi250514r23","volume-title":"Qualitative Research Practices: A Guide for Social Science Students and Researchers","author":"Ritchie","year":"2012"},{"key":"zoi250514r24","volume-title":"Improving Aging and Public Health Research: Qualitative and Mixed Methods","author":"Curry","year":"2006"},{"key":"zoi250514r1","unstructured":"Ramsey? C, Jacobson? G, Findlay? S, Cicchiello? A. Medicare Advantage: a policy primer, 2024 update. Explainer. Commonwealth Fund. January 31, 2024. Accessed March 20, 2025. https:\/\/www.commonwealthfund.org\/publications\/explainer\/2024\/jan\/medicare-advantage-policy-primer"},{"key":"zoi250514r2","unstructured":"MedPAC Report to the Congress: outpatient dialysis services. March 2024. Accessed March 20, 2025. https:\/\/www.medpac.gov\/wp-content\/uploads\/2024\/03\/Mar24_Ch5_MedPAC_Report_To_Congress_SEC.pdf"},{"key":"zoi250514r7","unstructured":"Findlay? S, Jacobson? G, Leonard? F. The role of marketing in Medicare beneficiaries\u2019 coverage choices.? Explainer. Commonwealth Fund. January 5, 2023. Accessed March 20, 2025. https:\/\/www.commonwealthfund.org\/publications\/explainer\/2023\/jan\/role-marketing-medicare-beneficiaries-coverage-choices"},{"key":"zoi250514r8","unstructured":"Biniek? JF, Cottrill? A, Sroczynski? N, . How health insurers and brokers are marketing Medicare. Kaiser Family Fund. September 20, 2023. Accessed March 20, 2025. https:\/\/www.kff.org\/medicare\/report\/how-health-insurers-and-brokers-are-marketing-medicare\/"},{"key":"zoi250514r9","unstructured":"Freed? M, Cottrill? A, Biniek? JF, Neuman? T. What do people with Medicare think about the role of marketing, shopping for Medicare options, and their coverage? Kaiser Family Fund. September 20, 2023. Accessed March 20, 2025. https:\/\/www.kff.org\/medicare\/report\/what-do-people-with-medicare-think-about-the-role-of-marketing-shopping-for-medicare-options-and-their-coverage\/"},{"key":"zoi250514r10","unstructured":"Jacobson? G, Leonard? F, Sciupac? E, Fisch-Friedman? M, Rapoport? R. The private plan pitch: seniors\u2019 experiences with Medicare marketing and advertising. Commonwealth Fund. September 12, 2023. Accessed March 20, 2025. https:\/\/www.commonwealthfund.org\/publications\/issue-briefs\/2023\/sep\/private-plan-pitch-seniors-experiences-medicare-marketing-advertising"},{"key":"zoi250514r11","unstructured":"The United States Committee on Finance. Deceptive marketing practices flourish in Medicare Advantage. November 2022. Accessed March 20, 2025. https:\/\/www.finance.senate.gov\/imo\/media\/doc\/Deceptive%20Marketing%20Practices%20Flourish%20in%20Medicare%20Advantage.pdf"},{"key":"zoi250514r12","unstructured":"Kirchhoff? SM. Medicare coverage of end-stage renal disease (ESRD). Congressional Research Service. August 16, 2018. Accessed March 20, 2025. https:\/\/sgp.fas.org\/crs\/misc\/R45290.pdf"},{"key":"zoi250514r13","unstructured":"Morgan? PC, Kirchhoff? SM. Medicare Advantage (MA) coverage of end stage renal disease (ESRD) and network requirement changes. Congressional Research Service. January 1, 2021. Accessed March 20, 2025. https:\/\/www.congress.gov\/crs-product\/R46655"},{"key":"zoi250514r15","unstructured":"114th Congress. 21st Century Cures Act. Public Law 114\u2013255 December 13, 2016. 130 Stat 1033-1344. Accessed December 1, 2024. https:\/\/www.congress.gov\/114\/plaws\/publ255\/PLAW-114publ255.pdf"},{"key":"zoi250514r16","unstructured":"Centers for Medicare & Medicaid Services. Medicare and Medicaid programs; contract year 2021 and 2022 policy and technical changes to the Medicare Advantage program, Medicare prescription drug benefit program, Medicaid program, Medicare cost plan program, and programs of all-inclusive care for the elderly. Fed Regist. 2021;86(11):5864-6135."},{"key":"zoi250514r19","unstructured":"Morgan? PC, Kirchhoff? SM. Medicare Advantage (MA) coverage of end stage renal disease (ESRD) and network requirement changes. CRS Report R46655. January 11, 2021. Accessed March 20, 2025. https:\/\/crsreports.congress.gov\/product\/pdf\/R\/R46655"},{"key":"zoi250514r26","unstructured":"Novick? B. Medicare Advantage and deceptive marketing. Center for Economic Policy Research. November 7, 2023. Accessed March 20, 2025. https:\/\/cepr.net\/report\/medicare-advantage-and-deceptive-marketing\/"},{"key":"zoi250514r27","unstructured":"Jaffe? S. Uncle Sam wants you \u2026 to help stop insurers\u2019 bogus Medicare Advantage sales tactics. Kaiser Family Foundation Health News. November 30, 2023. Accessed March 20, 2025. https:\/\/kffhealthnews.org\/news\/article\/medicare-advantage-deceptive-sales-tactics-federal-crackdown\/?utm_campaign=KHN%3A%20Topic-based&utm_medium=email&_hsmi=286559211&_hsenc=p2ANqtz--_8OdwGMzt0HPA9mYPjQfF5-"},{"key":"zoi250514r29","unstructured":"Freed? M, Biniek? JF, Damico? A, Neuman? T. Medicare Advantage in 2024: premiums, out-of-pocket limits, supplemental benefits, and prior authorization. Kaiser Family Fund. August 8, 2024. Accessed March 20, 2025. https:\/\/www.kff.org\/medicare\/issue-brief\/medicare-advantage-in-2024-premiums-out-of-pocket-limits-supplemental-benefits-and-prior-authorization\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2835404\/brazier_2025_oi_250514_1749568850.30899.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T11:00:30Z","timestamp":1750158030000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2835404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.16359","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]}}}